OPA3 Polyclonal Antibody, Cy5.5 Conjugated
Product Specifications
Background
OPA3 may play some role in mitochondrial processes. Defects in OPA3 are the cause of 3-methylglutaconic aciduria type 3 (MGA3), also known as optic atrophy plus syndrome, and of optic atrophy type 3 (OPA3), also known as autosomal dominant optic atrophy and cataract (ADOAC) .
Synonyms
FLJ22187; FLJ25932; Iraqi Jewish optic atrophy plus (3 methylglutaconicaciduria type 3) ; MGA3; MGC75494; OPA 3; OPA3 protein; Optic atrophy 3 (autosomal recessive, with chorea and spastic paraplegia) ; Optic atrophy 3 (Iraqi Jewish 'optic atrophy plus') ; Optic atrophy 3; Optic atrophy 3 protein.
Gene ID
80207
Swiss Prot
Q9H6K4
Cellular Locus
Cytoplasm
Host
Rabbit
Cross Reactivity
Mouse
Immunogen
1-100/179
Target
OPA3
Clonality
Polyclonal
Isotype
IgG
Conjugation
Cy5.5
Source
KLH conjugated synthetic peptide derived from human OPA3
Applications
IF (IHC-P), IF (IHC-F), IF (ICC)
Purification
Purified by Protein A.
Excitation Emission
675nm/694nm
Concentration
1µg/µl
Dilution
IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
80207
Predicted Cross Reactivity
Human, Dog, Cow, Sheep, Horse
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15104758 1 Vial
Lentiviral human ATP8A2 shRNA (UAS) - Lentiviral human ATP8A2 shRNA (UAS, GFP) plasmid
Ask
View Details 
MBS1198706-01 0.02 mg (E-Coli)
Recombinant Aliivibrio salmonicida 3-ketoacyl-CoA thiolase (fadA)
Ask
View Details MBS1198706-02 0.02 mg (Yeast)
Recombinant Aliivibrio salmonicida 3-ketoacyl-CoA thiolase (fadA)
Ask
View Details MBS1198706-03 0.1 mg (E-Coli)
Recombinant Aliivibrio salmonicida 3-ketoacyl-CoA thiolase (fadA)
Ask
View Details